GlassScriptPhysician profile
Brenton D Thomas
NPI 1235893249
$4,042.42
in general payments reported to CMS, 2019-2025
22 companies · $3,191 in 2025
The $3,191 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $803 · 2023: $48.79 · 2025: $3,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,222 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,222.44 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $794.22 | 2022-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Astrazeneca Pharmaceuticals LP | $767.56 | 2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $670.48 | 2025 | Nucala, Trelegy Ellipta, Arexvy |
| Verona Pharma, INC. | $367.77 | 2025 | Ohtuvayre |
| Insmed, INC. | $323.39 | 2025 | Brinsupri, Arikayce |
| Viatris Specialty LLC | $243.21 | 2025 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $139.60 | 2025 | Lumryz |
| Electromed, INC. | $98.03 | 2025 | Smartvest |
| Philips North America LLC | $90.47 | 2025 | Vest Therapy Und, Home Pi Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.84 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $79.49 | 2025 | Dupixent |
| Amgen INC. | $71.66 | 2025 | Tezspire |
| Pulmonx Corporation | $47.92 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Shionogi INC | $47.28 | 2025 | Fetroja |
| Jazz Pharmaceuticals INC. | $42.19 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $37.74 | 2025 | Glassia |
| Inspire Medical Systems, INC. | $35.96 | 2025 | Inspire |
| Pfizer INC. | $23.80 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $22.75 | 2022 | |
| Abbvie INC. | $21.28 | 2022 | |
| Ani Pharmaceuticals, INC. | $18.64 | 2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenton Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.